Skip to main content

Peer Review reports

From: Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancer

Original Submission
26 Jul 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
8 Sep 2022 Reviewed Reviewer Report
4 Oct 2022 Reviewed Reviewer Report - Jan Budczies
29 Nov 2022 Author responded Author comments - Dazhi Tian
Resubmission - Version 4
29 Nov 2022 Submitted Manuscript version 4
4 Dec 2022 Author responded Author comments - Dazhi Tian
Resubmission - Version 5
4 Dec 2022 Submitted Manuscript version 5
2 Jan 2023 Reviewed Reviewer Report - Jan Budczies
20 Jan 2023 Author responded Author comments - Dazhi Tian
Resubmission - Version 6
20 Jan 2023 Submitted Manuscript version 6
Publishing
30 Jan 2023 Editorially accepted
10 Feb 2023 Article published 10.1186/s12859-023-05165-8

You can find further information about peer review here.

Back to article page